Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Acoustic Device Determines Intracranial Pressure Values

By HospiMedica International staff writers
Posted on 21 Aug 2017
A new study describes how advanced acoustic signal analysis algorithms can be used to noninvasively evaluate intracranial pressure (ICP).

Researcher at Klinikum Stuttgart (Germany) and the University of Erlangen (Germany) used the HeadSense Medical (Netanya, Israel) HS-1000 device to generate and measure acoustic signals passing throughout the cranium. More...
The six-second, 66 dB bursts of sound are emitted in one ear and received by sensors located in the opposite ear. Advanced signal analysis algorithms are used to evaluate properties of the acoustic signals for constant evaluation of ICP. Data corresponding to the 6-second epoch are recorded and displayed on the device monitor.

In a study of the new device, the researchers tested noninvasive ICP monitoring in 14 patients who were already receiving treatment for traumatic brain injury and/or subarachnoid hemorrhage in an intensive care unit (ICU), with invasive intraventricular or intraparenchymal monitoring catheters already in place. The researchers then compared ICP values obtained from a total of 2,543 data points of continuous ICP monitoring using the noninvasive HS-1000 device with concurrent ICP values obtained using invasive monitoring.

The results showed a strong association between ICP values obtained using both the noninvasive and invasive methods. Differences in mean ICP values were +/- 3 mm Hg in 63% of data-paired readings, and +/- 5 mm Hg in 85% of data-paired readings, similar to the differences found in studies that compared invasive intraventricular to intraparenchymal monitoring. The resulting sensitivity and specificity of the noninvasive ICP monitoring were determined to be 0.7541 and 0.8887, respectively. The study was published on August 8, 2017, in the Journal of Neurosurgery.

“Overall, the findings show a good correlation between ICP values obtained using noninvasive and invasive methods of monitoring,” concluded lead author Oliver Ganslandt, MD, of Klinikum Stuttgart, and colleagues. “Use of the device could protect patients from infection and hemorrhage, potential risks of invasive ICP monitoring, and also could aid clinicians in deciding when invasive ICP monitoring may be appropriate.”

Normal human ICP is 20 mm Hg or lower, but in the presence of disease or trauma, brain tissues may swell or cerebrospinal fluid (CSF) may increase in volume, causing ICP to increase. ICP monitoring of critical-care patients provides clinicians with the knowledge of whether and when action must be taken to decrease ICP. To perform invasive ICP monitoring, a catheter must be inserted through the patients into brain parenchyma or into a ventricle. An intraventricular catheter can be used both to monitor ICP and to reduce ICP.

Related Links:
Klinikum Stuttgart
University of Erlangen
HeadSense Medical

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Hypodermic Syringe
SurTract™ Safety Syringe
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: A UTSW clinical trial studied a treatment strategy for kidney cancer with inferior vena cava tumor thrombus (IVC-TT) that used targeted radiation on the tumor thrombus followed by surgery to remove the kidney. (Photo courtesy of UT Southwestern)

Targeted Radiotherapy Before Surgery Improves Control of Kidney Cancer Thrombus

Inferior vena cava tumor thrombus occurs when kidney cancer extends into the body’s largest vein, potentially obstructing blood flow, progressing toward the heart, and making surgery more complex.... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Brain PET imaging could help identify Alzheimer’s patients most likely to benefit from available therapies (Image Credit: iStock)

Amyloid and Tau PET Guide Selection and Monitoring of Alzheimer’s Therapy

Alzheimer’s disease is the most common form of dementia and can be difficult to distinguish from other causes of cognitive decline. According to the World Health Organization (WHO), 57 million people were... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.